AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
194 hedge funds and large institutions have $1.99B invested in Amedisys in 2018 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.2% less ownership
Funds ownership: 97.44% → 97.24% (-0.2%)
7% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 69
25% less call options, than puts
Call options by funds: $3.36M | Put options by funds: $4.5M
Holders
194
Holding in Top 10
1
Calls
$3.36M
Puts
$4.5M
Top Buyers
| 1 | +$36.9M | |
| 2 | +$34.5M | |
| 3 | +$21.2M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$15.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$13.5M |
Top Sellers
| 1 | -$48.1M | |
| 2 | -$31.4M | |
| 3 | -$10.4M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$8.72M |
| 5 |
Two Sigma Investments
New York
|
-$7.33M |